Investors sold shares of Agilent Technologies, Inc. (NYSE:A) on strength during trading on Thursday following insider selling activity. $12.48 million flowed into the stock on the tick-up and $66.34 million flowed out of the stock on the tick-down, for a money net flow of $53.86 million out of the stock. Of all stocks tracked, Agilent Technologies had the 25th highest net out-flow for the day. Agilent Technologies traded up $0.82 for the day and closed at $66.71Specifically, CFO Didier Hirsch sold 1,200 shares of the stock in a transaction dated Wednesday, September 13th. The stock was sold at an average price of $66.00, for a total transaction of $79,200.00. Following the transaction, the chief financial officer now directly owns 164,202 shares in the company, valued at $10,837,332. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Jacob Thaysen sold 22,583 shares of the stock in a transaction dated Tuesday, November 28th. The stock was sold at an average price of $70.41, for a total value of $1,590,069.03. Following the transaction, the senior vice president now owns 63,042 shares in the company, valued at $4,438,787.22. The disclosure for this sale can be found here. Insiders sold 155,268 shares of company stock worth $10,637,706 over the last 90 days.
Several equities research analysts have commented on the company. Jefferies Group restated a “buy” rating and set a $66.00 price target on shares of Agilent Technologies in a research note on Wednesday, August 9th. BidaskClub lowered Agilent Technologies from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 12th. J P Morgan Chase & Co restated an “overweight” rating and set a $70.00 price target on shares of Agilent Technologies in a research note on Wednesday, August 16th. Bank of America restated an “equal weight” rating on shares of Agilent Technologies in a research note on Tuesday, August 15th. Finally, Janney Montgomery Scott upped their price target on Agilent Technologies from $65.00 to $70.00 and gave the stock a “buy” rating in a research note on Wednesday, August 16th. Six equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $68.34.
The company has a current ratio of 3.30, a quick ratio of 2.85 and a debt-to-equity ratio of 0.37. The company has a market capitalization of $21,185.94, a P/E ratio of 27.78, a PEG ratio of 1.99 and a beta of 1.27.
Agilent Technologies (NYSE:A) last posted its earnings results on Monday, November 20th. The medical research company reported $0.67 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.62 by $0.05. Agilent Technologies had a return on equity of 16.96% and a net margin of 15.30%. The business had revenue of $1.19 billion during the quarter, compared to analyst estimates of $1.17 billion. During the same quarter last year, the firm earned $0.59 earnings per share. The company’s revenue for the quarter was up 7.0% compared to the same quarter last year. equities analysts predict that Agilent Technologies, Inc. will post 2.58 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 24th. Stockholders of record on Tuesday, January 2nd will be paid a $0.149 dividend. The ex-dividend date is Friday, December 29th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.89%. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.13. Agilent Technologies’s dividend payout ratio (DPR) is 25.24%.
Several hedge funds have recently bought and sold shares of the company. Dupont Capital Management Corp acquired a new stake in Agilent Technologies during the 3rd quarter valued at approximately $101,000. Balentine LLC grew its stake in Agilent Technologies by 2.9% during the 2nd quarter. Balentine LLC now owns 1,794 shares of the medical research company’s stock valued at $106,000 after purchasing an additional 50 shares in the last quarter. Sun Life Financial INC grew its stake in Agilent Technologies by 26,144.4% during the 2nd quarter. Sun Life Financial INC now owns 2,362 shares of the medical research company’s stock valued at $140,000 after purchasing an additional 2,353 shares in the last quarter. Acrospire Investment Management LLC grew its stake in Agilent Technologies by 92.3% during the 2nd quarter. Acrospire Investment Management LLC now owns 2,500 shares of the medical research company’s stock valued at $148,000 after purchasing an additional 1,200 shares in the last quarter. Finally, Parallel Advisors LLC grew its stake in Agilent Technologies by 5.3% during the 2nd quarter. Parallel Advisors LLC now owns 2,623 shares of the medical research company’s stock valued at $157,000 after purchasing an additional 131 shares in the last quarter.
WARNING: This piece of content was reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this piece of content on another domain, it was copied illegally and reposted in violation of US and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://ledgergazette.com/2017/12/07/investors-sell-agilent-technologies-a-on-strength-on-insider-selling.html.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.